For an adult with a capillary blood glucose of 20 mg/dL, how many 50 % dextrose (D‑50 W) vials should be administered?

Severe Hypoglycemia Management: D50 Dosing for CBG 20 mg/dL

For an adult with capillary blood glucose of 20 mg/dL, administer ONE vial (25 mL) of 50% dextrose (D50W) initially—equivalent to 12.5 grams—then recheck glucose at 15 minutes and repeat dosing as needed until blood glucose exceeds 70 mg/dL. 1

Initial Treatment Protocol

• Stop any insulin infusion immediately before administering dextrose to prevent recurrent hypoglycemia 2
• The FDA-approved dose for insulin-induced hypoglycemia is 10-25 grams of dextrose (20-50 mL of 50% dextrose), with repeated doses and supportive treatment required in severe cases 3
• Titrate the initial dose based on the severity of hypoglycemia—a CBG of 20 mg/dL represents severe, life-threatening hypoglycemia requiring prompt treatment 1
• One standard D50W vial contains 25 mL = 12.5 grams of dextrose, which falls within the recommended 10-20 gram initial dose range 1

Critical 15-Minute Recheck

• Mandatory blood glucose recheck at 15 minutes post-administration is essential because dextrose effects peak at 5 minutes but decline toward baseline by 30 minutes 1
• If blood glucose remains below 70 mg/dL at 15 minutes, administer another vial (12.5 grams) using the same titrated approach 1
• For patients with neurologic injury (stroke, traumatic brain injury), use a higher treatment threshold of 100 mg/dL rather than 70 mg/dL 1, 2

Dosing Strategy to Avoid Overcorrection

• Traditional 25-gram D50 boluses frequently cause overcorrection, with post-treatment glucose averaging 169 mg/dL versus 112 mg/dL with lower titrated doses 1
• Research demonstrates that 5-gram aliquots (10 mL of D50W) repeated every 1-2 minutes achieve symptom resolution with fewer adverse events compared to full 25-gram boluses 1
• Avoid giving the entire 50 mL (25 grams) at once—rapid or repeated large D50 boluses have been associated with cardiac arrest and hyperkalemia 1

Administration Technique

• Administer slowly through a large peripheral vein using a small-bore needle to minimize venous irritation and thrombosis risk 1
• The maximum safe infusion rate is 0.5 g/kg/hour for peripheral administration, though emergency hypoglycemia treatment requires faster administration 3
• Obtain a blood glucose specimen before injecting dextrose when feasible, but do not delay treatment awaiting laboratory results in emergencies 3

Monitoring After Treatment

• Continue blood glucose monitoring every 1-2 hours for patients on insulin infusions 1
• Additional monitoring at 15 minutes and 60 minutes after dextrose administration is recommended 1
• Check serum electrolytes (especially potassium) every 2-4 hours during ongoing dextrose therapy, as dextrose infusion causes intracellular potassium shift and hypokalemia risk 1

Alternative Approach: D10 Titration

• If D50W is unavailable or you wish to minimize overcorrection risk, administer 5-gram aliquots of 10% dextrose (50 mL) every 1-2 minutes until symptoms resolve 2, 4
• D10 administration results in lower post-treatment glucose levels (6.2 mmol/L vs 8.5 mmol/L with D50) and no reported adverse events in large observational studies 5, 6
• However, D10 requires approximately 4 minutes longer to achieve symptom resolution and has higher rates of requiring subsequent doses (19.5% vs 8.1%) 5

Critical Safety Warnings

• Severe hypoglycemia is independently associated with significantly higher mortality (OR 3.233,95% CI [2.251,4.644]; p <0.0001) 1
• Do not use hypotonic solutions like 5% dextrose alone for acute hypoglycemia—these are insufficient for rapid correction 1, 2
• Any episode of severe hypoglycemia requires reevaluation of the diabetes management plan 7
• In unconscious patients unable to protect their airway, use intramuscular glucagon (1 mg) if IV access is unavailable 2